Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rice bran enzymatic extract (RBEE) is a functional food/dietary supplement ingredient obtained by enzymatic hydrolysis of rice bran, the outer layer of Oryza sativa seeds. Enzymatic treatments—typically using proteases (such as alcalase or flavorzyme) and endoglucanase—serve to inactivate endogenous lipases and lipoxygenases (which cause rancidity), increase the soluble fiber content, improve retention of bioactive compounds (γ-oryzanol, α-tocopherol, polyphenols, ubiquinol-10), and produce bioactive peptides and oligosaccharides with antioxidant and prebiotic properties. RBEE is rich in vitamins (especially B-complex), peptides, and short-chain carbohydrates, and has demonstrated antioxidant, anti-inflammatory, metabolic modulating, and neuroprotective effects in preclinical studies. Its major indications in research and supplements include support for metabolic health, cardiovascular protection, modulation of neuroinflammation, and overall antioxidant action[1][3][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on rice bran enzymatic extract.